Synopsis: This article discusses why complete medical records are so essential to pharmaceutical research, shares common roadblocks sponsors experience when trying to capture patients’ complete health data, and explains why Q-Centrix, an MRO company, is well positioned to provide sponsors with both de-identified clinical data and patient-authorized medical records from a wide range of care settings.
On average, patients see four or five different providers every year. For life sciences researchers relying on patients’ medical records for observational studies, this fragmentation can translate into data gaps, study delays, and flawed analyses.
Our newest article explores why complete medical records are essential for observational studies and discusses how Q-Centrix, as part of MRO, helps study sponsors efficiently obtain the records they need for research. Through our extensive network—spanning more than 2,000 hospitals and health systems and over 7,000 clinics—sponsors can obtain patient-consented records from a broader range of care settings.
This Article Is For:
- Pharmaceutical researchers looking for an efficient way to obtain patient-consented medical records across a wide range of care settings
- Research sponsors who want to accelerate observational study timelines and generate insights that are more accurate, inclusive, and actionable
- Life sciences leaders interested in learning about how our solutions provide sponsors with the real world data they need for observational studies
